Michael Lee-Chin joins the ITM Supervisory Board

The philosophy of Michael Lee-Chin and Portland Holdings is to “do well and do good” – building strong businesses that are giving back to society. Over the years, Portland has contributed significant capital and human resources to a variety of initiatives in education, culture, health care and humanitarian assistance. For his entrepreneurial and philanthropic work, Mr. Lee-Chin has received numerous awards and honors, including degrees from several distinguished universities. In 2008, he was awarded one of Jamaica’s highest honors, the Order of Jamaica for his significant contributions in business and philanthropy. In February 2018, he was appointed to the Order of Ontario, the Canadian province’s highest honor, reserved for those whose contributions have shaped the province, the country and beyond.

“We are extremely delighted that Michael joined our supervisory board. His exceptional business acumen and his entrepreneurial spirit will further support our strong growth and our goal to improve the wellbeing and quality of life of cancer patients worldwide by bringing a new generation of targeted radiopharmaceuticals to the market,” said Udo J. Vetter, Chairman of the ITM Supervisory Board.

“I really look forward to helping ITM’s exceptional team shaping the future of Targeted Radionuclide Therapy and effective cancer treatments in general. ITM’s dedication, innovative pipeline and passion for the well-being of those in need align perfectly with the values I strive to achieve with my other business ventures,” commented Michael Lee-Chin. “Targeted Radionuclide Therapy has the potential to revolutionize cancer therapy. I am grateful; I now have the opportunity to play my part in making this type of treatment available to even more patients worldwide.”

- Ends -

View source version on businesswire.com: https://www.businesswire.com/news/home/20190603005581/en/